28
Aug
2017
13:45
BST
Live Stream
Improving care decisions after coronary revascularisation Satellite Symposium at the ESC Congress 2017
-
Views:
7976
-
Likes:
1
Overview
Live stream in association with AER and Boehringer Ingelheim
Chapters
→ Georg Nickenig / Antithrombotic strategies post-PCI: what do we know so far?
→ Christopher Cannon / Dual vs triple antithrombotic therapy: new evidence
→ Todd Villines / Safety, efficacy, control: choosing the right OAC for our patients
→ Panel discussion and Q&A
Monday 28th August 2017
ESC Congress 2017, Barcelona
Chair: Christopher Cannon, USA
Faculty:
Prof Georg Nickenig
Todd Villines
This live stream is supported by
Agenda
Learning Objectives
- Understand the latest data from the RE-DUAL PCI trial of dual vs triple therapy in patients with atrial fibrillation post-percutaneous coronary intervention (PCI)
- Recognize the potential impact of these data on clinical practice
- Consider which factors are most important when choosing an oral anticoagulant, including key insights from real-world evidence
Faculty Biographies
Prof Georg Nickenig
Dr Georg Nickenig is a Full Professor and Chair, Department of Internal Medicine and Polyclinic II, University Hospital Bonn, Germany.
Dr Nickenig completed his doctoral degree in Clinical Medicine from the University of Bonn.
Todd Villines
Todd Villines has served as the Director of Anticoagulation Services and is an active clinician, teacher, and researcher in the areas of anticoagulation therapy, outcomes research, and cardiovascular imaging and prevention.